Your browser doesn't support javascript.
loading
Importance of Systematic Diagnostic Testing in Idiopathic Ventricular Fibrillation: Results From the Dutch iVF Registry.
Groeneveld, Sanne A; Verheul, Lisa M; van der Ree, Martijn H; Mulder, Bart A; Scholten, Marcoen F; Alings, Marco; van der Voort, Pepijn; Bootsma, Marianne; Evertz, Reinder; Balt, Jippe C; Yap, Sing-Chien; Doevendans, Pieter A F M; Postema, Pieter G; Wilde, Arthur A M; Volders, Paul G A; Hassink, Rutger J.
Afiliación
  • Groeneveld SA; Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Verheul LM; Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • van der Ree MH; Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Mulder BA; Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands.
  • Scholten MF; Department of Cardiology, Medisch Spectrum Twente, Enschede, the Netherlands.
  • Alings M; Department of Cardiology, Amphia Hospital, Breda, the Netherlands.
  • van der Voort P; Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands.
  • Bootsma M; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Evertz R; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Balt JC; Department of Cardiology, St. Antonius hospital, Nieuwegein, the Netherlands.
  • Yap SC; Department of Cardiology, Erasmus MC, Rotterdam, the Netherlands.
  • Doevendans PAFM; Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands; Netherlands Heart Institute, Utrecht, the Netherlands.
  • Postema PG; Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, the Netherlands; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
  • Wilde AAM; Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, the Netherlands; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
  • Volders PGA; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart; Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands.
  • Hassink RJ; Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart. Electronic address: R.J.Hassink@umcutrecht.nl.
JACC Clin Electrophysiol ; 9(3): 345-355, 2023 03.
Article en En | MEDLINE | ID: mdl-36752476
ABSTRACT

BACKGROUND:

Idiopathic ventricular fibrillation (iVF) is a diagnosis of exclusion. Systematic diagnostic testing is important to exclude alternative causes for VF. The early use of "high yield" testing, including cardiac magnetic resonance (CMR), exercise testing, and sodium channel blocker provocation, has been increasingly recognized.

OBJECTIVES:

The purpose of this study was to investigate the importance and consistency of systematic diagnostic testing in iVF.

METHODS:

This study included 423 iVF patients from 11 large secondary and tertiary hospitals in the Netherlands. Clinical characteristics and diagnostic testing data were ascertained.

RESULTS:

IVF patients experienced the index event at a median age of 40 years (IQR 28-52 years), and 61% were men. The median follow-up time was 6 years (IQR 2-12 years). Over the years, "high yield" diagnostic tests were increasingly performed (mean 68% in 2000-2010 vs 75% in 2011-2021; P < 0.001). During follow-up, 38 patients (9%) originally labeled as iVF received an alternative diagnosis. Patients in whom "high-yield" diagnostic tests were consistently performed during the initial work-up received an alternative diagnosis less frequently during follow-up (HR 0.439; 95% CI 0.219-0.878; P = 0.020). Patients who received an alternative diagnosis during follow-up had a worse prognosis in terms of cardiac death (P = 0.012) with a trend toward more implantable cardioverter-defibrillator therapy (P = 0.055).

CONCLUSIONS:

Although adherence to (near) complete diagnostic testing in this population of iVF patients increased over the years, patients with iVF still undergo varying levels of diagnostic evaluation. The latter leads to initial underdiagnosis of alternative conditions and is associated with a worse prognosis. Our results underscore the importance of early systematic diagnostic assessment in patients with apparent iVF.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Electrocardiografía / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JACC Clin Electrophysiol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Electrocardiografía / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: JACC Clin Electrophysiol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos